Its levels begin to rise very early in CKD, before the alterations in calcium, phosphorus, and PTH levels [54,55], and, in addition, its production is stimulated by reduced oxygenation, iron deficiency, and Epo [96]. This evidence concerns the gene EPO and chronic kidney disease.